Litcius/Paper detail

Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study

Beatrice Anna Zannetti, Francesco Saraceni, Claudia Cellini, Elisabetta Fabbri, Federica Monaco, Attilio Guarini, Daniele Laszlò, Massimo Martino, Attilio Olivieri, Manuela Imola, Patrizia Tosi, Martina Chiarucci, Eliana Zuffa, Francesco Lanza

2021Transplantation and Cellular Therapy34 citationsDOIOpen Access PDF

Topics & Concepts

CyclophosphamideGranulocyte colony-stimulating factorMultiple myelomaMedicineMobilizationOncologyStem cellGranulocyteInternal medicineChemotherapyBiologyHistoryGeneticsArchaeologyMultiple Myeloma Research and TreatmentsProtein Degradation and InhibitorsPeptidase Inhibition and Analysis
Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study | Litcius